Colorimetric transform was measured at dual wavelengths of 405 and 630 nm on a Microplate Autoreader

craz S, et al. Natural killer cell receptor repertoire and their ligands, and the threat of CMV infection following kidney transplantation. Am J Transplant 8: 26742683. 15. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, et al. Effectiveness of donor all-natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 20972100. 16. Auchincloss H, Jr., Sachs DH Xenogeneic transplantation. Annu Rev Immunol 16: 433470. 17. Manilay JO, Sykes M Natural killer cells and their part in graft rejection. Curr Opin Immunol 10: 532538. 18. Blancho G, Buzelin F, Dantal J, Hourmant M, Cantarovich D, et al. Evidence that early acute renal failure may perhaps be mediated by CD3- CD16+ cells in a kidney graft recipient with massive granular lymphocyte proliferation. Transplantation 53: 12421247. 19. Kroemer A, Xiao X, Degauque N, Edtinger K, Wei H, et al. The innate NK cells, allograft rejection, plus a essential function for IL-15. J Immunol 180: 78187826. 20. Seiler M, Brabcova I, Viklicky O, Hribova P, Rosenberger C, et al. Heightened expression on the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy soon after kidney transplantation. Am J Transplant 7: 423433. 21. Beilke JN, Kuhl NR, Van Kaer L, Gill RG NK cells market islet allograft tolerance by means of a perforin-dependent mechanism. Nat Med 11: 10591065. 22. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation by way of perforin-mediated killing of donor allogeneic dendritic cells. Blood 112: 661671. 23. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 203: 18511858. 24. Wai LE, Fujiki M, Takeda S, Martinez OM, Krams SM Rapamycin, but not cyclosporine or FK506, alters all-natural killer cell function. Transplantation 85: 145149. 25. Shao-Hsien C, Lang I, Gunn H, Lydyard P Impact of in vitro cyclosporin. A treatment on human organic and antibody-dependent cell-mediated cytotoxicity. Transplantation 35: 127129. 26. Introna M, Allavena P, Spreafico F, Mantovani A Inhibition of human organic killer activity by cyclosporin A. Transplantation 31: 113116. 27. Wasik M, Gorski A, Stepien-Sopniewska B, Lagodzinski Z Effect of FK506 versus cyclosporine on human organic and antibody-dependent cytotoxicity reactions in vitro. Transplantation 51: 268270. 28. Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, et al. The unexpected impact of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood 110: 15301539. 29. Petersson E, Qi Z, Ekberg H, Ostraat O, Dohlsten M, et al. Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation 63: 11381144. 30. Alter G, Malenfant JM, Altfeld M CD107a as a functional The adhesion frequency was T cell IL-2 ELISA Splenocytes from 2D2 or SMARTA mice had been incubated inside a 24-well plate using the indicated concentration of peptide marker for the identification of organic killer cell activity. J Immunol Methods 294: 1522. 31. Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G Partnership among CD107a expression and cytotoxic activity. Cell Immunol 254: 149154. 32. Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19: 835840. 33. Pores-Fernando AT, Gaur S, Doyon MY, Zweifach A Calcineurindependent lytic granule exocytosis in NK-92 all-natural killer cells. Cell Immunol 254: 105109.